Publications by authors named "Stephan Moser"

Claim this Profile
E
Effects of a community pharmacy-based structured medication review on drug-related problems in all-comers with polypharmacy: a randomized, controlled, double-blind, parallel-group trial.
Thorsten Bischof, Alexander Schmidt-Ilsinger, Magdalena Hoppel, Anton Kreuzer, Stefanie Briganser, Stephan Moser

Front Med (Lausanne)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive Infections: A Prospective Cohort Study.
Severin Bausch, Sarah Dräger, Panteleimon Charitos-Fragkakis, Adrian Egli, Stephan Moser

Antibiotics (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection.
Laura Hermann, Verena Schöning, Sarah Dräger, Katharina Rentsch, Stephan Moser

J Antimicrob Chemother· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Endothelial Cell Activation with Acute Kidney Injury during Coronary Angiography and the Influence of Recombinant Human C1 Inhibitor-A Secondary Analysis of a Randomized, Placebo-Controlled, Double-Blind Trial.
Stephan Moser, Laura Araschmid, Anneza Panagiotou, Leo H Bonati, Tobias Breidthardt

Biomedicines· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.
Pascal Urwyler, Marina Leimbacher, Panteleimon Charitos, Stephan Moser, Ingmar A F M Heijnen

Front Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting thromboinflammation in COVID-19 - A narrative review of the potential of C1 inhibitor to prevent disease progression.
Pascal Urwyler, Stephan Moser, Marten Trendelenburg, Parham Sendi, Michael Osthoff

Mol Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study.
Flavio Bruni, Panteleimon Charitos, Maurin Lampart, Stephan Moser, Martin Siegemund

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probability of pharmacological target attainment with flucloxacillin in Staphylococcus aureus bloodstream infection: a prospective cohort study of unbound plasma and individual MICs.
Stephan Moser, Sophia Rehm, Nicolas Guertler, Vladimira Hinic, Sarah Dräger

J Antimicrob Chemother· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
Pascal Urwyler, Panteleimon Charitos, Stephan Moser, Ingmar A F M Heijnen, Marten Trendelenburg

Trials· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System.
Pascal Urwyler, Stephan Moser, Panteleimon Charitos, Ingmar A F M Heijnen, Melanie Rudin

Front Immunol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Hematochezia and right-sided upper abdominal pain after puncture of a liver abscess in a 75-year-old male].
Nicolas Gürtler, Doris Linnemann, Stephan Moser, Sarah Dräger, Michael Osthoff

Internist (Berl)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Trial of Recombinant Human C1-Esterase-Inhibitor in the Prevention of Contrast-Induced Kidney Injury.
Anneza Panagiotou, Marten Trendelenburg, Ingmar A F M Heijnen, Stephan Moser, Leo H Bonati

JACC Cardiovasc Interv· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment.
Karin Kozbial, Stephan Moser, Ramona Al-Zoairy, Remy Schwarzer, Christian Datz

Liver Int· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease.
Stephan Moser, Karin Kozbial, Hermann Laferl, Angelika Schütz, Thomas Reiberger

Eur J Gastroenterol Hepatol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of peginterferon plus ribavirin in patients receiving opioid substitution therapy : Final results of the Austrian PegHope study.
Michael Gschwantler, Hermann Laferl, Wolfgang Vogel, Wolfgang Korak, Stephan Moser

Wien Klin Wochenschr· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rare complication of endoloop-assisted polypectomy: adhesion of snare and endoloop.
Alexander Tischer, Theresia Schober, Margret Karner, Stephan Moser, Michael Schleicher

Endoscopy· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment.
Karin Kozbial, Stephan Moser, Remy Schwarzer, Hermann Laferl, Ramona Al-Zoairy

J Hepatol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early decrease of liver stiffness after initiation of antiviral therapy in patients with chronic hepatitis C.
Stephan Moser, Enisa Gutic, Michael Schleicher, Michael Gschwantler

Dig Liver Dis· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct Observed Therapy of Chronic Hepatitis C With Interferon-Free All-Oral Regimens at a Low-Threshold Drug Treatment Facility-a New Concept for Treatment of Patients With Borderline Compliance Receiving Opioid Substitution Therapy.
Angelika Schìtz, Stephan Moser, Katharina Marchart, Hans Haltmayer, Michael Gschwantler

Am J Gastroenterol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon/Ribavirin-Free Antiviral Treatment in Septuagenarians and Octogenarians With Chronic Hepatitis C.
Rafael Stern, Stephanie Hametner, Al-Zoairy Ramona, Stephan Moser, Asia Karpi

Am J Gastroenterol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence that thalidomide is effective in recurrent bleeding from watermelon stomach associated with liver cirrhosis.
Stephan Moser, Alexander Tischer, Asia Karpi, Michael Schleicher, Susanne Stavjanik

Endoscopy· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplacental traffic after in utero mesenchymal stem cell transplantation.
Carolyn Troeger, Iryna Perahud, Stephan Moser, Wolfgang Holzgreve

Stem Cells Dev· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of three-dimensional image registration methodologies for in vivo micro-computed tomography.
Steven K Boyd, Stephan Moser, Michael Kuhn, Robert J Klinck, Peter L Krauze

Ann Biomed Eng· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis